{
    "address": "Gustavslundsvagen 34",
    "city": "Bromma",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W6709J120",
    "description": "OncoZenge AB operates as a pharmaceutical company. The company is headquartered in Bromma, Stockholm. The company went IPO on 2021-02-12. The firm was founded in 2020 and is located in Bromma, Sweden. The company develops products for supportive care of cancer patients.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "N/A",
    "ggroup": "N/A",
    "gind": "N/A",
    "gsector": "N/A",
    "gsubind": "N/A",
    "ipo": "2021-02-12",
    "isin": "SE0015504097",
    "logo": "",
    "marketCapitalization": 138.2163,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Pharmaceutical Preparation Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Oncozenge AB",
    "phone": "",
    "sedol": "BMVHXB5",
    "shareOutstanding": 11.713244,
    "state": "STOCKHOLM",
    "ticker": "ONCOZ.ST",
    "weburl": "https://oncozenge.se/"
}